Advisor Group Holdings, Inc. Tg Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 67,235 shares of TGTX stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,235
Previous 75,587 11.05%
Holding current value
$1.99 Million
Previous $1.34 Million 16.96%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$17.21 - $25.28 $143,737 - $211,138
-8,352 Reduced 11.05%
67,235 $1.57 Million
Q2 2024

Aug 13, 2024
BUY
$13.32 - $19.19 $256,596 - $369,676
19,264 Added 34.2%
75,587 $1.34 Million
Q1 2024

May 10, 2024
SELL
$13.02 - $21.3 $560,146 - $916,368
-43,022 Reduced 43.31%
56,323 $856,000
Q4 2023

Feb 12, 2024
SELL
$6.68 - $18.81 $130,333 - $367,001
-19,511 Reduced 16.42%
99,345 $1.7 Million
Q3 2023

Nov 13, 2023
BUY
$8.36 - $26.5 $354,238 - $1.12 Million
42,373 Added 55.4%
118,856 $993,000
Q2 2023

Aug 10, 2023
BUY
$15.48 - $35.0 $330,343 - $746,900
21,340 Added 38.7%
76,483 $1.9 Million
Q1 2023

May 12, 2023
BUY
$10.23 - $19.34 $191,260 - $361,580
18,696 Added 51.3%
55,143 $829,000
Q4 2022

Feb 10, 2023
BUY
$5.01 - $11.83 $30,095 - $71,062
6,007 Added 19.73%
36,447 $431,000
Q3 2022

Nov 14, 2022
SELL
$4.57 - $8.4 $12,169 - $22,369
-2,663 Reduced 8.04%
30,440 $179,000
Q2 2022

Aug 10, 2022
SELL
$3.74 - $10.66 $4,974 - $14,177
-1,330 Reduced 3.86%
33,103 $142,000
Q1 2022

May 04, 2022
SELL
$7.81 - $20.45 $3,834 - $10,040
-491 Reduced 1.41%
34,433 $328,000
Q3 2021

Nov 05, 2021
BUY
$21.78 - $40.45 $128,480 - $238,614
5,899 Added 20.32%
34,924 $1.16 Million
Q2 2021

Aug 02, 2021
BUY
$32.5 - $48.96 $143,130 - $215,619
4,404 Added 17.89%
29,025 $1.13 Million
Q1 2021

May 13, 2021
BUY
$41.61 - $54.3 $34,120 - $44,526
820 Added 3.45%
24,621 $1.19 Million
Q4 2020

Feb 10, 2021
SELL
$25.27 - $54.9 $272,562 - $592,151
-10,786 Reduced 31.19%
23,801 $1.24 Million
Q3 2020

Nov 12, 2020
BUY
$18.49 - $27.24 $209,972 - $309,337
11,356 Added 48.88%
34,587 $927,000
Q2 2020

Aug 14, 2020
SELL
$8.9 - $21.84 $34,816 - $85,438
-3,912 Reduced 14.41%
23,231 $454,000
Q1 2020

May 18, 2020
BUY
$7.14 - $15.99 $193,801 - $434,016
27,143 New
27,143 $268,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email